Skip to main content
SpringerLink
Log in

Alendronic acid treats osteoporosis in paediatric patients with connective tissue diseases who have severe bone loss

  • Clinical study
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alendronic acid treats osteoporosis in paediatric patients with connective tissue diseases who have severe bone loss. Inpharma Wkly. 1263, 17 (2000). https://doi.org/10.2165/00128413-200012630-00043

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200012630-00043

Keywords

Search

Navigation